GenKardia provides cutting-edge treatments to help people with heart failure live better lives.
GenKardia has raised $250K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
GenKardia's investors include Cure.
GenKardia is headquartered in New York, United States.
GenKardia provides cutting-edge treatments to help people with heart failure live better lives.
GenKardia is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GenKardia — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/genkardia. Accessed August 14, 2026.
VCBacked. (2025). GenKardia — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/genkardia
{{cite web |title=GenKardia — Funding & Investors |url=https://www.vcbacked.co/company/genkardia |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated